Cargando…

Development and external validation of a radiomics model for assessment of HER2 positivity in men and women presenting with gastric cancer

BACKGROUND: To develop and externally validate a conventional CT-based radiomics model for identifying HER2-positive status in gastric cancer (GC). METHODS: 950 GC patients who underwent pretreatment CT were retrospectively enrolled and assigned into a training cohort (n = 388, conventional CT), an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Huiping, Liang, Pan, Yong, Liuliang, Cheng, Ming, Zhang, Yan, Huang, Minggang, Gao, Jianbo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Vienna 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9889592/ https://www.ncbi.nlm.nih.gov/pubmed/36720737 http://dx.doi.org/10.1186/s13244-022-01361-x

Ejemplares similares

Radiomics Study for Differentiating Focal Hepatic Lesions Based on Unenhanced CT Images
por: Zhao, Xitong, et al.
Publicado: (2022)

Expanding applications of MRI-based radiomics in HER2-positive breast cancer
por: Park, Vivian Y.
Publicado: (2020)

Are radiomic spleen features useful for assessing the differentiation status of advanced gastric cancer?
por: Lyu, Dongbo, et al.
Publicado: (2023)

HER2-positive gastric cancer
por: Boku, Narikazu
Publicado: (2013)

Her-2 Positive Gastric Cancer Presented with Thrombocytopenia and Skin Involvement: A Case Report
por: Arslan, Deniz, et al.
Publicado: (2014)

Antitumor activity of pan‐HER inhibitors in HER2‐positive gastric cancer
por: Yoshioka, Takahiro, et al.
Publicado: (2018)

MRI-Based Radiomics to Differentiate between Benign and Malignant Parotid Tumors With External Validation
por: Piludu, Francesca, et al.
Publicado: (2021)

Development and External Validation of a PET Radiomic Model for Prognostication of Head and Neck Cancer
por: Noortman, Wyanne A., et al.
Publicado: (2023)

Radiomics preoperative-Fistula Risk Score (RAD-FRS) for pancreatoduodenectomy: development and external validation
por: Ingwersen, Erik W, et al.
Publicado: (2023)

Loss of HER2 Positivity after Trastuzumab in HER2-Positive Gastric Cancer: Is Change in HER2 Status Significantly Frequent?
por: Ishimine, Yu, et al.
Publicado: (2015)

Analysis of MRI and CT-based radiomics features for personalized treatment in locally advanced rectal cancer and external validation of published radiomics models
por: Shahzadi, Iram, et al.
Publicado: (2022)

HER2 heterogeneity is a poor prognosticator for HER2-positive gastric cancer
por: Kaito, Akio, et al.
Publicado: (2019)

Development and Validation of an Ultrasound-Based Radiomics Nomogram for Identifying HER2 Status in Patients with Breast Carcinoma
por: Guo, Yinghong, et al.
Publicado: (2022)

Targeting HER2-positive gastric cancer with a novel (18)F-labeled Z(HER2:342) probe
por: Pan, Yunyun, et al.
Publicado: (2019)

External Validation of a Radiomics Model for the Prediction of Complete Response to Neoadjuvant Chemoradiotherapy in Rectal Cancer
por: Bordron, Anaïs, et al.
Publicado: (2022)

Cycle-consistent adversarial networks improves generalizability of radiomics model in grading meningiomas on external validation
por: Park, Yae Won, et al.
Publicado: (2022)

Positive prognostic value of HER2-HER3 co-expression and p-mTOR in gastric cancer patients
por: Cao, Guo-dong, et al.
Publicado: (2017)

HER2-positive gastric cancer identified by serum HER2: A case report
por: SAITO, MAYUKO, et al.
Publicado: (2016)

Efficacy and safety of trastuzumab as maintenance or palliative therapy in advanced HER2-positive gastric cancer
por: Fu, Xiaomin, et al.
Publicado: (2018)

HER2 Positive Gastric Carcinomas and Their Clinico-Pathological Characteristics
por: Ognjenovic, Ljubomir, et al.
Publicado: (2018)

Cardiotoxicity of trastuzumab in patients with HER2-positive gastric cancer
por: Soo Park, Ji, et al.
Publicado: (2017)

Challenges and future of HER2-positive gastric cancer therapy
por: Ma, Chenzhe, et al.
Publicado: (2023)

A CT-based radiomics signature for prediction of HER2 overexpression and treatment efficacy of trastuzumab in advanced gastric cancer
por: Ma, Tingting, et al.
Publicado: (2022)

Preoperative (18)F-FDG PET/CT radiomics analysis for predicting HER2 expression and prognosis in gastric cancer
por: Liu, Qiufang, et al.
Publicado: (2023)

HER2-positive double primary tumor of gastric and breast cancer occur synchronously in a patient: A case report
por: OUYANG, QUCHANG, et al.
Publicado: (2016)

A New Tool for Breast Anthropometric Measurements: Presentation and Validation for Women and Men
por: Mikołajczyk, Maksym, et al.
Publicado: (2019)

Validation of the AJCC prognostic stage for HER2-positive breast cancer in the ShortHER trial
por: Dieci, Maria Vittoria, et al.
Publicado: (2019)

Radiomics in esophageal and gastric cancer
por: Sah, Bert-Ram, et al.
Publicado: (2019)

Contrast-Enhanced CT Parameters of Gastric Adenocarcinoma: Can Radiomic Features Be Surrogate Biomarkers for HER2 Over-Expression Status?
por: Wang, Na, et al.
Publicado: (2020)

MRI-Based Radiomic Signature as a Prognostic Biomarker for HER2-Positive Invasive Breast Cancer Treated with NAC
por: Li, Qin, et al.
Publicado: (2020)

Trastuzumab deruxtecan for the treatment of patients with HER2-positive gastric cancer
por: Kotani, Daisuke, et al.
Publicado: (2021)

Predicting the risk of Chronic Kidney Disease in Men and Women in England and Wales: prospective derivation and external validation of the QKidney(® )Scores
por: Hippisley-Cox, Julia, et al.
Publicado: (2010)

Clinical impact of intratumoral HER2 heterogeneity on trastuzumab efficacy in patients with HER2-positive gastric cancer
por: Wakatsuki, Takeru, et al.
Publicado: (2018)

HER2 copy number as predictor of disease-free survival in HER2-positive resectable gastric adenocarcinoma
por: Liu, Zimin, et al.
Publicado: (2021)

Development and validation of a predictive model combining clinical, radiomics, and deep transfer learning features for lymph node metastasis in early gastric cancer
por: Zeng, Qingwen, et al.
Publicado: (2022)

External Validation of an MRI-Derived Radiomics Model to Predict Biochemical Recurrence after Surgery for High-Risk Prostate Cancer
por: Bourbonne, Vincent, et al.
Publicado: (2020)

Differentiation of recurrent glioblastoma from radiation necrosis using diffusion radiomics with machine learning model development and external validation
por: Park, Yae Won, et al.
Publicado: (2021)

External Validation of Robust Radiomic Signature to Predict 2-Year Overall Survival in Non-Small-Cell Lung Cancer
por: Jha, Ashish Kumar, et al.
Publicado: (2023)

PTEN loss and level of HER2 amplification is associated with trastuzumab resistance and prognosis in HER2-positive gastric cancer
por: Kim, Chan, et al.
Publicado: (2017)

Difference of molecular alterations in HER2-positive and HER2-negative gastric cancers by whole-genome sequencing analysis
por: Zhou, Chenfei, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_65oe0cio3u7l21mrfc8elgcufl